Cargando…
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis
Great progress in the treatment of patients with multiple myeloma (MM) has been made due to the development of novel drugs. Patients with relapsed/refractory MM (RRMM) can be enrolled in early-phase clinical trials, but their performance across the last decade is unknown. We conducted a meta-analysi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921415/ https://www.ncbi.nlm.nih.gov/pubmed/33649328 http://dx.doi.org/10.1038/s41408-021-00441-3 |